Combination therapy for painful diabetic neuropathy is safe and effective

BMJ. 2023 Apr 21:381:866. doi: 10.1136/bmj.p866.

Abstract

The studyTesfaye S, Sloan G, Petrie J, et al. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Lancet 2022;400:680-90.To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/combination-therapy-for-painful-diabetic-neuropathy-is-safe-and-effective/.

Publication types

  • Randomized Controlled Trial
  • Multicenter Study

MeSH terms

  • Amitriptyline / therapeutic use
  • Analgesics / therapeutic use
  • Diabetes Mellitus*
  • Diabetic Neuropathies* / drug therapy
  • Double-Blind Method
  • Duloxetine Hydrochloride / therapeutic use
  • Humans
  • Pregabalin / therapeutic use
  • Treatment Outcome

Substances

  • Pregabalin
  • Analgesics
  • Amitriptyline
  • Duloxetine Hydrochloride